Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers.
Nat Commun. 2020 Nov 9;11(1):5660. doi: 10.1038/s41467-020-19464-8.
Nat Commun. 2020.
PMID: 33168830
Free PMC article.
Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies.
Saini SK, Holmberg-Thydén S, Bjerregaard AM, Unnikrishnan A, Dorfmüller S, Platzbecker U, Tirado-Gonzalez I, Bönig H, El Fassi D, Grønbæk K, Pimanda J, Medyouf H, Hadrup SR.
Saini SK, et al. Among authors: holmberg thyden s.
Leukemia. 2022 Nov;36(11):2734-2738. doi: 10.1038/s41375-022-01705-y. Epub 2022 Oct 8.
Leukemia. 2022.
PMID: 36209321
Free PMC article.
No abstract available.
Item in Clipboard
A user's guide to multicolor flow cytometry panels for comprehensive immune profiling.
Holmberg-Thyden S, Grønbæk K, Gang AO, El Fassi D, Hadrup SR.
Holmberg-Thyden S, et al.
Anal Biochem. 2021 Aug 15;627:114210. doi: 10.1016/j.ab.2021.114210. Epub 2021 May 24.
Anal Biochem. 2021.
PMID: 34033799
Free article.
Item in Clipboard
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial.
Holmberg-Thydén S, Dufva IH, Gang AO, Breinholt MF, Schejbel L, Andersen MK, Kadivar M, Svane IM, Grønbæk K, Hadrup SR, El Fassi D.
Holmberg-Thydén S, et al.
Cancer Immunol Immunother. 2022 Feb;71(2):433-444. doi: 10.1007/s00262-021-02993-6. Epub 2021 Jul 4.
Cancer Immunol Immunother. 2022.
PMID: 34218294
Free PMC article.
Clinical Trial.
Item in Clipboard
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine.
O'Connell CL, Baer MR, Ørskov AD, Saini SK, Duong VH, Kropf P, Hansen JW, Tsao-Wei D, Jang HS, Emadi A, Holmberg-Thyden S, Cowland J, Brinker BT, Horwood K, Burgos R, Hostetter G, Youngblood BA, Hadrup SR, Issa JP, Jones P, Baylin SB, Siddiqi I, Grønbaek K.
O'Connell CL, et al. Among authors: holmberg thyden s.
Clin Cancer Res. 2022 Dec 15;28(24):5306-5316. doi: 10.1158/1078-0432.CCR-22-1810.
Clin Cancer Res. 2022.
PMID: 36222848
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite